Stay updated on MBG453 Combination with Azacitidine Clinical Trial
Sign up to get notified when there's something new on the MBG453 Combination with Azacitidine Clinical Trial page.

Latest updates to the MBG453 Combination with Azacitidine Clinical Trial page
- CheckyesterdayChange DetectedDecember 2023 added a termination notice for the sabatolimab program after failures of Phase II/III objectives, not due to safety concerns. 2025-12-12 updates posted Results, Limitations and Caveats, Adverse Events, and Outcome Measures, and related sections; the 2025-06-24 'Results Submitted' entry was removed.SummaryDifference0.3%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe Record History now shows a new revision (v3.3.2) returned on 2025-11-17 with added sections for Adverse Events, Outcome Measures (Results), Participant Flow, Contacts/Locations, and Study Description, replacing the prior v3.2.0, and notes that Quality Control Has Not Concluded along with Limitations and Caveats.SummaryDifference0.4%

- Check29 days agoChange DetectedRemoved the site-wide funding/operating status notice about potential data delays due to a lapse in government funding and links to cc.nih.gov and opm.gov.SummaryDifference0.2%

- Check44 days agoChange DetectedThe Record History page now presents an extended history of past submissions and version-selection controls, while the underlying study details remain the same.SummaryDifference0.0%

- Check65 days agoChange DetectedA comprehensive set of new study-design and reporting sections was added, indicating a transition to a fuller, structured clinical-study/documentation framework.SummaryDifference3%

- Check72 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference7%

Stay in the know with updates to MBG453 Combination with Azacitidine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MBG453 Combination with Azacitidine Clinical Trial page.